HealthCor Catalio Acquisition Corp. (HCAQ): Price and Financial Metrics

HealthCor Catalio Acquisition Corp. (HCAQ): $10.92

0.49 (+4.70%)

POWR Rating

Component Grades








HCAQ Price/Volume Stats

Current price $10.92 52-week high $11.00
Prev. close $10.43 52-week low $9.48
Day low $10.06 Volume 159,900
Day high $10.93 Avg. volume 114,974
50-day MA $9.98 Dividend yield N/A
200-day MA $9.93 Market Cap 232.75M

HCAQ Stock Price Chart Interactive Chart >

HealthCor Catalio Acquisition Corp. (HCAQ) Company Bio

HealthCor Catalio Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

HCAQ Latest News Stream

Event/Time News Detail
Loading, please wait...

HCAQ Latest Social Stream

Loading social stream, please wait...

View Full HCAQ Social Stream

Latest HCAQ News From Around the Web

Below are the latest news stories about HealthCor Catalio Acquisition Corp that investors may wish to consider to help them evaluate HCAQ as an investment opportunity.

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market

Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it has completed its business combination with HealthCor Catalio Acquisition Corp. (Nasdaq: HCAQ) ("HealthCor"), a special purpose acquisition company sponsored by leading healthcare funds HealthCor Management, L.P. and Catalio Capital Management, LP, and Liminal Sciences, Inc. ("Liminal"), a medical device development company dedicated to non-in

Yahoo | December 22, 2021

HealthCor Catalio Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hyperfine, Inc. and Liminal Sciences, Inc.

HealthCor Catalio Acquisition Corp. (Nasdaq: HCAQ) ("HealthCor") reminds its shareholders to vote at the upcoming extraordinary general meeting of HealthCor's shareholders (the "Special Meeting") on December 21, 2021 to, among other matters, approve the proposed business combination with Hyperfine, Inc. ("Hyperfine") and Liminal Sciences, Inc. ("Liminal") and, in connection therewith, HealthCor's change of domicile to Delaware (the "Domestication").

Yahoo | December 15, 2021

Moore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law Firm

Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

Yahoo | July 13, 2021

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of HealthCor Catalio Acquisition Corp. (Nasdaq - HCAQ)

BALA CYNWYD, PA / ACCESSWIRE / July 8, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of HealthCor Catalio Acquisition Corp. ("HealthCor Catalio" or the "Company") (Nasdaq - HCAQ) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which HealthCor Catalio, a special purpose acquisition company, will combine with Hyperfine, Inc.

Yahoo | July 8, 2021

Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp.

GUILFORD, Conn., July 08, 2021--Hyperfine, Inc. and Liminal Sciences, Inc. to be listed on Nasdaq through a business combination with HealthCor Catalio Acquisition Corp.

Yahoo | July 8, 2021

Read More 'HCAQ' Stories Here

HCAQ Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!